• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchMetaVia
    Picture of MetaVia logo

    MTVA — MetaVia News Story

    $1.380.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      $9.09m
    • Enterprise Value
      -$3.54m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • MTVA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    MTVA Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:33 AM

    Picture of MetaVia logoMetaVia
    15/01/2026 14:33
    NASDAQ TRADE HALT  MTVA.O  VOLATILITY TRADING PAUSE AT 09:33 AM
    

    Recent news on MetaVia

    See all news
    • MetaVia Inc reports results for the quarter ended June 30 - Earnings Summary

      06/08/2026 23:11
    • MetaVia Q2 net loss widens on higher R&D spending

      06/08/2026 21:39
    • MetaVia Inc expected to post a loss of 82 cents a share - Earnings Preview

      03/08/2026 14:59
    • Brief: Biostem Technologies Announces Appointment Of Three New Members To Its Board Of Directors

      09/06/2026 12:02
    • MetaVia Q1 net loss widens slightly as expenses rise

      14/05/2026 21:19

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.